2 active not recruiting, 2 completed, 1 enrolling by invitation. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Active not recruiting 2, Completed 2, Enrolling by invitation 1 |
Follow eplontersen: new trials by email Literature Review of eplontersen trials Research Report on eplontersen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Amyloidosis (3) · Cardiomyopathies (1) · Polyneuropathies (1)
Ionis Pharmaceuticals, Inc. (4) · AstraZeneca (1)
Argentina (4) · Australia (4) · Brazil (4) · Canada (4) · France (4) · Italy (4) · Portugal (4) · Spain (4) · Sweden (4) · United States (4) · Germany (3) · Greece (3) · Austria (2) · Belgium (2) · Cyprus (2)
PMID 38065307, PMID 33638113, PMID 36525140, PMID 37768671, PMID 41913562, PMID 41937511, PMID 42104840, PMID 42663301, PMID 42669065, PMID 42742182
2019 (2)